bristol-myers squibb international company unlimited companyEstimated Valuation
€71.9m
Pomanda estimates the enterprise value of BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY at €71.9m based on a Turnover of €136.1m and 0.53x industry multiple (adjusted for size and gross margin).
bristol-myers squibb international company unlimited companyEstimated Valuation
€0
Pomanda estimates the enterprise value of BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY at €0 based on an EBITDA of €-22.5m and a 4.55x industry multiple (adjusted for size and gross margin).
bristol-myers squibb international company unlimited companyEstimated Valuation
€968.4m
Pomanda estimates the enterprise value of BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY at €968.4m based on Net Assets of €371m and 2.61x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bristol-myers Squibb International Company Unlimited CompanyOverview
Bristol-myers Squibb International Company Unlimited Company is a live company located in d15 t867, 662895 with a Companies House number of IE181050. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in November 1991, it's largest shareholder is
bristol-myers squibb delta company limited
with a 100% stake. Bristol-myers Squibb International Company Unlimited Company is a mature,
mega sized company, Pomanda has estimated its turnover at
€136.1m with
rapid
growth in recent years.
Bristol-myers Squibb International Company Unlimited Company Health Check
Pomanda's financial health check has awarded Bristol-Myers Squibb International Company Unlimited Company a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating2.5out of 5
4 Strong
0 Regular
5 Weak
Size
annual sales of €136.1m, make it larger than the average company (€851k)
€136.1m - Bristol-myers Squibb International Company Unlimited Company
€851k - Industry AVG
Growth
3 year (CAGR) sales growth of 119%, show it is growing at a faster rate (8.5%)
119% - Bristol-myers Squibb International Company Unlimited Company
8.5% - Industry AVG
Production
with a gross margin of -2.8%, this company has a higher cost of product (58.3%)
-2.8% - Bristol-myers Squibb International Company Unlimited Company
58.3% - Industry AVG
Profitability
an operating margin of -16.5% make it less profitable than the average company (7.4%)
-16.5% - Bristol-myers Squibb International Company Unlimited Company
7.4% - Industry AVG
Employees
with 10 employees, this is above the industry average (8)
10 - Bristol-myers Squibb International Company Unlimited Company
8 - Industry AVG
Pay Structure
on an average salary of €138.9k, the company has a higher pay structure (€57.1k)
€138.9k - Bristol-myers Squibb International Company Unlimited Company
€57.1k - Industry AVG
Efficiency
resulting in sales per employee of €13.6m, this is more efficient (€132.6k)
€13.6m - Bristol-myers Squibb International Company Unlimited Company
€132.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Bristol-myers Squibb International Company Unlimited Company
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Bristol-myers Squibb International Company Unlimited Company
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Bristol-myers Squibb International Company Unlimited Company
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 12 weeks, this is less cash available to meet short term requirements (24 weeks)
12 weeks - Bristol-myers Squibb International Company Unlimited Company
24 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 88%, this is a higher level of debt than the average (55.9%)
88% - Bristol-myers Squibb International Company Unlimited Company
55.9% - Industry AVG
BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY financials
EXPORT
Bristol-Myers Squibb International Company Unlimited Company's latest turnover from December 2023 is €136.1 million and the company has net assets of €371 million. According to their latest financial statements, Bristol-Myers Squibb International Company Unlimited Company has 10 employees and maintains cash reserves of €662.5 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Turnover
136,061,000
23,721,000
22,418,000
12,870,000
16,058,000
16,829,000
124,528,000
25,568,000
Other Income Or Grants
Cost Of Sales
139,854,000
26,483,000
2,011,000
2,470,000
6,123,000
4,242,000
2,145,000
4,284,000
Gross Profit
-3,793,000
-2,762,000
20,407,000
10,400,000
9,935,000
12,587,000
122,383,000
21,284,000
Admin Expenses
18,657,061
33,414,477
3,074,798
-6,362,339
8,413,147
3,205,861
-16,504,787
10,077,554
Operating Profit
-22,450,061
-36,176,477
17,332,202
16,762,339
1,521,853
9,381,139
138,887,787
11,206,446
Interest Payable
Interest Receivable
Pre-Tax Profit
-8,578,000
-28,843,000
17,212,000
15,837,000
3,217,000
9,973,000
114,524,000
10,887,000
Tax
-2,459,000
2,313,000
-2,380,000
-1,996,000
-808,000
-1,325,000
-1,094,000
-1,546,000
Profit After Tax
-11,037,000
-26,530,000
14,832,000
13,841,000
2,409,000
8,648,000
113,430,000
9,341,000
Dividends Paid
261,000,000
Retained Profit
-11,037,000
-26,530,000
14,832,000
13,841,000
-258,591,000
8,648,000
113,430,000
9,341,000
Employee Costs
1,389,000
1,487,000
1,151,000
1,005,000
802,000
736,000
1,031,000
766,000
Number Of Employees
10
10
10
8
8
8
8
7
EBITDA*
-22,450,061
-36,176,477
17,332,202
16,762,339
1,521,853
9,381,139
138,887,787
11,206,446
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Tangible Assets
Intangible Assets
Investments & Other
1,266,827,000
1,266,049,000
1,265,000,000
500,000,000
1,282,000,000
1,282,000,000
2,232,000,000
2,386,341,000
Debtors (Due After 1 year)
1,265,000,000
1,265,000,000
1,265,000,000
500,000,000
1,282,000,000
1,282,000,000
2,232,000,000
2,386,341,000
Total Fixed Assets
1,266,827,000
1,266,049,000
1,265,000,000
500,000,000
1,282,000,000
1,282,000,000
2,232,000,000
2,386,341,000
Stock & work in progress
Trade Debtors
1,000
12,000
2,000
15,000
Group Debtors
1,154,884,000
1,214,591,000
1,113,726,000
1,528,332,000
448,817,000
346,671,000
613,989,000
555,664,000
Misc Debtors
3,473,000
5,654,000
1,050,000
66,000
1,964,000
1,297,000
4,223,000
3,674,000
Cash
662,452,000
359,548,000
507,043,000
152,764,000
136,604,000
259,214,000
113,749,000
384,093,000
misc current assets
5,803,000
698,000
3,371,000
2,828,000
1,753,000
64,000
248,000
342,000
total current assets
1,826,612,000
1,580,491,000
1,625,190,000
1,683,990,000
589,139,000
607,258,000
732,211,000
943,788,000
total assets
3,093,439,000
2,846,540,000
2,890,190,000
2,183,990,000
1,871,139,000
1,889,258,000
2,964,211,000
3,330,129,000
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
2,720,793,000
2,545,424,000
2,595,816,000
2,004,694,000
1,364,548,000
1,126,957,000
2,091,783,000
2,563,270,000
other short term finances
1,358,000
689,000
1,800,000
413,000
497,000
454,000
2,604,000
330,000
hp & lease commitments
other current liabilities
267,000
333,000
593,000
1,988,000
247,000
226,000
212,000
208,000
total current liabilities
2,722,418,000
2,546,446,000
2,598,209,000
2,007,095,000
1,365,292,000
1,127,637,000
2,094,599,000
2,563,808,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
2,722,418,000
2,546,446,000
2,598,209,000
2,007,095,000
1,365,292,000
1,127,637,000
2,094,599,000
2,563,808,000
net assets
371,021,000
300,094,000
291,981,000
176,895,000
505,847,000
761,621,000
869,612,000
766,321,000
total shareholders funds
371,021,000
300,094,000
291,981,000
176,895,000
505,847,000
761,621,000
869,612,000
766,321,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Operating Activities
Operating Profit
-22,450,061
-36,176,477
17,332,202
16,762,339
1,521,853
9,381,139
138,887,787
11,206,446
Depreciation
Amortisation
Tax
-2,459,000
2,313,000
-2,380,000
-1,996,000
-808,000
-1,325,000
-1,094,000
-1,546,000
Stock
Debtors
-61,888,000
105,469,000
351,378,000
295,616,000
102,802,000
-1,220,234,000
-95,480,000
2,945,694,000
Creditors
Accruals and Deferred Income
-66,000
-260,000
-1,395,000
1,741,000
21,000
14,000
4,000
208,000
Deferred Taxes & Provisions
Cash flow from operations
36,912,939
-139,592,477
-337,820,798
-279,108,661
-102,067,147
1,228,304,139
233,277,787
-2,935,825,554
Investing Activities
capital expenditure
Change in Investments
778,000
1,049,000
765,000,000
-782,000,000
-950,000,000
-154,341,000
2,386,341,000
cash flow from investments
-778,000
-1,049,000
-765,000,000
782,000,000
950,000,000
154,341,000
-2,386,341,000
Financing Activities
Bank loans
Group/Directors Accounts
175,369,000
-50,392,000
591,122,000
640,146,000
237,591,000
-964,826,000
-471,487,000
2,563,270,000
Other Short Term Loans
669,000
-1,111,000
1,387,000
-84,000
43,000
-2,150,000
2,274,000
330,000
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
81,964,000
34,643,000
100,254,000
-342,793,000
2,817,000
-116,639,000
-10,139,000
756,980,000
interest
cash flow from financing
258,002,000
-16,860,000
692,763,000
297,269,000
240,451,000
-1,083,615,000
-479,352,000
3,320,580,000
cash and cash equivalents
cash
302,904,000
-147,495,000
354,279,000
16,160,000
-122,610,000
145,465,000
-270,344,000
384,093,000
overdraft
change in cash
302,904,000
-147,495,000
354,279,000
16,160,000
-122,610,000
145,465,000
-270,344,000
384,093,000
bristol-myers squibb international company unlimited company Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for bristol-myers squibb international company unlimited company. Get real-time insights into bristol-myers squibb international company unlimited company's credit score, group structure and payment trends.
Bristol-myers Squibb International Company Unlimited Company Competitor Analysis
Perform a competitor analysis for bristol-myers squibb international company unlimited company by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mega companies, companies in Region Area area or any other competitors across 12 key performance metrics.
bristol-myers squibb international company unlimited company Ownership
BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY group structure
Bristol-Myers Squibb International Company Unlimited Company has no subsidiary companies.
BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY
IE181050
BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY Shareholders
The largest shareholders in Bristol-Myers Squibb International Company Unlimited Company include Bristol-Myers Squibb Delta Company Limited and Bms Bermuda Nominees L.L.C..
bristol-myers squibb delta company limited
100%
bms bermuda nominees l.l.c.
0%
bristol-myers squibb international company unlimited company directors
Bristol-Myers Squibb International Company Unlimited Company currently has 5 directors.
The longest serving directors include
DECLAN HAYES (Sep 2000) and
BRIAN O'GRADY (Aug 2005).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023
net assets
371m
+0.24%
total assets
3.1b
+0.09%
cash
662.5m
+0.84%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
bristol-myers squibb international company unlimited company company details
company number
IE181050
Type
ULC - PRIVATE UNLIMITED COMPANY
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
November 1991
age
34
incorporated
IE
ultimate parent company
BRISTOL-MYERS SQUIBB CO
accounts
Full Accounts
last accounts submitted
December 2023
previous names
bristol-myers squibb international company (November 1991)
accountant
-
auditor
DELOITTE IRELAND LLP
address
plaza 254, blanchardstown corporate park 2 dublin 15, d15 t867, dublin 15dublin, 662895
Bank
CITIBANK EUROPE PLC
Legal Advisor
ARTHUR COX
bristol-myers squibb international company unlimited company Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bristol-myers squibb international company unlimited company.
bristol-myers squibb international company unlimited company Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY. This can take several minutes, an email will notify you when this has completed.
bristol-myers squibb international company unlimited companyCompanies House Filings - See Documents
